Organon & Co | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Adcock Ingram Holdings ZAR 5.41B 63.09M 2024-06
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Celltrion KRW 16.89T 38.11B 2024-09
Cspc Pharmaceutical CNY 34.85B 167.05M 2024-06
Dianthus Therapeutics USD 337.9M 20.32M 2024-09
Ecofibre AUD 40.97M 10.34M 2024-06
Gilead Sciences USD 19.33B 856M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Kangmei Pharma CNY 7.04B 22.02M 2024-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 482.76M 41.02M 2024-06
Malin Corporation EUR 118.2M 8.7M 2024-06
Medical Developments International AUD 45.73M 29.96M 2024-06
Merck USD 46.31B 1.81B 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Novartis USD 44.05B 729M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Organon & Co USD 493M 349M 2024-09
Pharma Mar EUR 208.36M 26.19M 2024-12
Qiagen NV USD 3.57B 37.35M 2024-12
Sartorius EUR 3.78B 33.4M 2024-09
Sino Biopharmaceutical CNY 42.12B 3.95B 2024-06
Tilray USD 3.47B 5.16M 2024-11



Organon & Co Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.